Keywords: b-ms, buspar, open, generic, competition, after, lawsuit

B-MS' BuSpar open to generic competition after lawsuit verdict?

Article | 15 March 2001

Print This

Bristol-Myers Squibb has lost a lawsuit trying to block genericcompetition to its anxiolytic drug BuSpar (buspirone), opening the way for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in